It is a chemicals and materials private limited company based in Hyderabad, Telangana, India, established in 2009.
2009 | Hyderabad, Telangana, India | ActiveSri Indu Drugs India Private Limited, a active private limited company, was established on 10 August 2009 in Hyderabad, Telangana, India. Engaging in industrial chemicals within the trade sector, it holds CIN: U24232TG2009PTC064701. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Rahul Tammineedi (Additional Director), Indu Govina (Director), Govina Ramakrishna (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 153/10, Road No. 22 Vivekananda Nagar Colony, Kukatpally, Hyderabad, Telangana, 500072.
U24232TG2009PTC064701
064701
10 August 2009
₹0.50 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sri Indu Drugs India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Tammineedi | Additional Director | 29 Aug 2022 | Current |
| Indu Govina | Director | 10 Aug 2009 | Current |
| Govina Ramakrishna | Director | 10 Aug 2009 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sri Indu Drugs India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 70.44% increase. The company also saw a substantial improvement in profitability, with a 532.54% increase in profit. The company's net worth Soared by an impressive increase of 421.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sri Indu Drugs India had a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sri Indu Drugs India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sri Indu Drugs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Indu Drugs India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sri Indu Drugs India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Sri Indu Drugs India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity Rahul Tammineedi was appointed as a Additional Director was appointed as a Additional Director on 29 Aug 2022 & has been associated with this company since 3 years 3 months . was completed.
Indu Govina was appointed as a Director was appointed as a Director on 10 Aug 2009 & has been associated with this company since 16 years 3 months . was recorded as a recent event.
Progress on Govina Ramakrishna was appointed as a Director was appointed as a Director on 10 Aug 2009 & has been associated with this company since 16 years 3 months . was documented.
Progress on Sri Indu Drugs India Private Limited was registered on 10 Aug 2009 with Roc Hyderabad & aged 16 years 3 months as per MCA records. was documented.
The CIN of Sri Indu Drugs India Private Limited is U24232TG2009PTC064701.
Sri Indu Drugs India Private Limited is headquartered at Plot No. 153/10, Road No. 22 Vivekananda Nagar Colony, Kukatpally, Hyderabad, Telangana, 500072.
Sri Indu Drugs India Private Limited was incorporated on 10 August 2009.
The current directors of Sri Indu Drugs India Private Limited are
The primary industry of Sri Indu Drugs India Private Limited is Trade.
Sri Indu Drugs India Private Limited is unlisted.
The authorized capital of Sri Indu Drugs India Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Sri Indu Drugs India Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX